Muhlack, S.; MĂĽsch, P.; Konietzka, S.; Woitalla, D.; Przuntek, H.; MĂĽller, T.
Impact of Oral Fast Release Amantadine on Movement Performance in Patients with Parkinson’s Disease. Pharmaceutics 2010, 2, 313-320.
https://doi.org/10.3390/pharmaceutics2030313
AMA Style
Muhlack S, MĂĽsch P, Konietzka S, Woitalla D, Przuntek H, MĂĽller T.
Impact of Oral Fast Release Amantadine on Movement Performance in Patients with Parkinson’s Disease. Pharmaceutics. 2010; 2(3):313-320.
https://doi.org/10.3390/pharmaceutics2030313
Chicago/Turabian Style
Muhlack, Siegfried, Patricia MĂĽsch, Sandra Konietzka, Dirk Woitalla, Horst Przuntek, and Thomas MĂĽller.
2010. "Impact of Oral Fast Release Amantadine on Movement Performance in Patients with Parkinson’s Disease" Pharmaceutics 2, no. 3: 313-320.
https://doi.org/10.3390/pharmaceutics2030313
APA Style
Muhlack, S., MĂĽsch, P., Konietzka, S., Woitalla, D., Przuntek, H., & MĂĽller, T.
(2010). Impact of Oral Fast Release Amantadine on Movement Performance in Patients with Parkinson’s Disease. Pharmaceutics, 2(3), 313-320.
https://doi.org/10.3390/pharmaceutics2030313